All Journals > Clinical Infectious Diseases > 15 March 2008 > Community‐Acquired MRSA Bacteremia

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

15 March 2008

Volume 46, Number 6
Clinical Infectious Diseases 2008;46:799–806
1058-4838/2008/4606-0003$15.00
DOI: 10.1086/527389
MAJOR ARTICLE

Comparison of Both Clinical Features and Mortality Risk Associated with Bacteremia due to Community‐Acquired Methicillin‐Resistant Staphylococcus aureus and Methicillin‐Susceptible S. aureus

Jiun‐Ling Wang,1

Shey‐Ying Chen,2

Jann‐Tay Wang,1

Grace Hui‐Min Wu,4,5

Wen‐Chu Chiang,2

Po‐Ren Hsueh,1,3

Yee‐Chun Chen,1 and

Shan‐Chwen Chang1

Departments of 1Internal Medicine, 2Emergency Medicine, and 3Laboratory Medicine, National Taiwan University Hospital, and 4Institute of Preventive Medicine and 5Centre of BioStatistics Consultation, College of Public Health, National Taiwan University, Taipei, Taiwan

Background.The majority of research about community‐acquired methicillin‐resistant Staphylococcus aureus (CA‐MRSA) infection has focused on skin and soft‐tissue infections. No literature has been published on the clinical features and outcomes of adult patients with CA‐MRSA bacteremia in comparison with patients with community‐acquired methicillin‐susceptible S. aureus (CA‐MSSA) bacteremia.

Methods.From 1 January 2001 through 31 December 2006, the demographic data and outcome of 215 consecutive adult patients admitted to a tertiary care center in Taiwan with S. aureus bacteremia (age, >16 years) who fulfilled the criteria for community‐acquired S. aureus bacteremia were collected for analysis.

Results.The mean age (±SD) was years. There were 30 patients (14%) with CA‐MRSA bacteremia and 185 (86%) patients with CA‐MSSA bacteremia. Cutaneous abscess (odds ratio, 5.46; 95% confidence interval, 1.66–17.94) and necrotizing pneumonia (odds ratio, 24.81; 95% confidence interval, 2.63–234.03) were the independent predictors of CA‐MRSA bacteremia; endovascular infection was the only independent predictor of CA‐MSSA bacteremia. After Cox regression analysis, the independent significant risk factors for 30‐day mortality included increased age, shock, and thrombocytopenia (<100,000 cells/μL). After adjustment, the day 30 mortality of patients with CA‐MRSA bacteremia was not significantly higher than that of patients with CA‐MSSA bacteremia (adjusted hazard ratio, 1.01; 95% confidence interval, 0.30–3.39; ). Most (92%) of 25 available CA‐MRSA isolates were multilocus sequence typing 59.

Conclusions.The number of adult patients with CA‐MRSA bacteremia increased with time, and the disease was associated with more necrotizing pneumonia and cutaneous abscess but less endovascular infection than was CA‐MSSA bacteremia. Patients with CA‐MRSA bacteremia did not have higher mortality than did patients with CA‐MSSA, even though most of the patients with CA‐MRSA bacteremia did not receive empirical glycopeptide therapy.

Received 5 June 2007; accepted 31 October 2007; electronically published 11 February 2008.

Reprints or correspondence: Dr. Shan‐Chwen Chang, Div. of Infectious Diseases, Dept. of Internal Medicine, National Taiwan University Hospital, 7, Chung‐Shan S. Rd., Taipei, Taiwan 100 ().

Cited by

Chung‐Chih Lin, MD; Jiun‐Ling Wang, MD; Chi‐Ying Lin, MD; Shey‐Ying Chen, MD; Jann‐Tay Wang, MD; Kwan‐Dun Wu, MD, PhD; Shan‐Chwen Chang, MD, PhD. (2009) Reply to Tsai et al. •. Infection Control and Hospital Epidemiology 30:7, 718-719
Online publication date: 1-Jul-2009.
Steven Y. C. Tong, Emma J. Bishop, Rachael A. Lilliebridge, Allen C. Cheng, Zornitsa Spasova‐Penkova, Deborah C. Holt, Philip M. Giffard, Malcolm I. McDonald, Bart J. Currie, and Craig S. Boutlis. (2009) Community‐Associated Strains of Methicillin‐Resistant Staphylococcus aureus and Methicillin‐Susceptible S. aureus in Indigenous Northern Australia: Epidemiology and Outcomes. The Journal of Infectious Diseases 199:10, 1461-1470
Online publication date: 15-May-2009.
M. Li, B. A. Diep, A. E. Villaruz, K. R. Braughton, X. Jiang, F. R. DeLeo, H. F. Chambers, Y. Lu, M. Otto. (2009) From the Cover: Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proceedings of the National Academy of Sciences 106:14, 5883-5888
Online publication date: 7-May-2009.
CrossRef
P. Federspil, P.A. Federspil, U. Geipel. (2009) Methicillinresistente Staphylokokken (MRSA, MRSE) im Nasen-, Nasennebenhöhlenbereich und Sputum. HNO 57:4, 395-407
Online publication date: 1-May-2009.
CrossRef
Bo H. Chao, Jason M. Kidd, Alan W. Dow. (2009) Methicillin-resistant Staphylococcus aureus bacteremia due to prostatic abscess. Journal of Hospital Medicine 4:1, E9-E11
Online publication date: 1-Feb-2009.
CrossRef
Chung‐Chih Lin, MD; Jiun‐Ling Wang, MD; Chi‐Ying Lin, MD; Shey‐Ying Chen, MD; Jann‐Tay Wang, MD; Kwan‐Dun Wu, MD, PhD; Shan‐Chwen Chang, MD, PhD. (2009) Methicillin‐Resistant Staphylococcus aureus Bacteremia in Patients With End‐Stage Renal Disease in Taiwan: Distinguishing Between Community‐Associated and Healthcare‐Associated Strains •. Infection Control and Hospital Epidemiology 30:1, 89-92
Online publication date: 1-Jan-2009.
Lisa L Maragakis, Eli N Perencevich, Sara E Cosgrove. (2008) Clinical and economic burden of antimicrobial resistance. Expert Review of Anti-infective Therapy 6:5, 751-763
Online publication date: 1-Nov-2008.
CrossRef
Natasha VDV Ratnaraja, Peter M Hawkey. (2008) Current challenges in treating MRSA: what are the options?. Expert Review of Anti-infective Therapy 6:5, 601-618
Online publication date: 1-Nov-2008.
CrossRef
Close Popup